Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

Introduction

Pepsin is a proteolytic enzyme which is widely used as a digestive aid. Its dose is 300 mg - 1 gm per day in divided doses. Its biological half-life is around 3.5 hrs. Pepsin is active only in the acidic pH of the stomach; its activity decreases tremendously in the basic pH. So, it is required to retain in the stomach for maximum proteolytic activity. The goal of the current effort is to develop and assess an oral controlled floating drug delivery system for pepsin that will shorten its stay in the stomach and result in a longer effect.

Methods

The 12-hour sustained effect of pepsin floating microspheres was planned. This also improves the stability of the Pepsin by immobilizing them on the microsphere. Pepsin is widely used in chronic gastritis, so developing a floating drug delivery system is therefore necessary. In light of the aforementioned principles, a critical need for the creation of a dosage form to administer Pepsin in the stomach and boost the enzyme's effectiveness, enabling sustained action, was identified. The current study used a methodical strategy to create floating microspheres of Pepsin dosage forms.

Results

Optimization was done for floating ability, yield, entrapment efficiency, and release study using different concentrations of ethylcellulose & HPMC E4M. For parameter optimization and to demonstrate the significant impact of variables, 32 full factorial designs were used. The manufactured microspheres had good encapsulation rates, excellent floating, & excellent micromeritic properties as single-unit dosage forms.

Conclusion

It has been demonstrated that pepsin prepared as floating microspheres can be used to improve proteolytic activity and extend pepsin's gastric residence.

Loading

Article metrics loading...

/content/journals/cdth/10.2174/0115748855274979231228103038
2024-01-30
2024-11-22
Loading full text...

Full text loading...

References

  1. JainS. AgrawalG. JainN. Floating microspheres as drug delivery system: Newer approaches.Curr. Drug Deliv.20085322022310.2174/15672010878491172118673266
    [Google Scholar]
  2. MohamedJ.M.M. Ameliorated stomach specific floating microspheres for emerging health pathologies using polymeric Konjac Glucomannan-based domperidone.Biomed Res Int20222022367094610.1155/2022/3670946
    [Google Scholar]
  3. NeelamegarajanR. Formulation and evaluation of floating microspheres of Levofloxacin hemihydrate for the treatment of H. pylori infection.Journal of Pharmaceutical Chemistry20228
    [Google Scholar]
  4. LeeJ-H. ParkT.G. ChoiH-K. J.-H. Lee, T. G. Park, H.-K. Choi Development of oral drug delivery system using floating microspheres.J. Microencapsul.199916671572910.1080/02652049928866310575624
    [Google Scholar]
  5. PrajapatiV.C. PatelP.R. PrajapatiG.B. Formulation, optimization and evaluation of sustained release microsphere of ketoprofen.J. Pharm. Bioallied Sci.201245Suppl. 110110.4103/0975‑7406.9415623066178
    [Google Scholar]
  6. PiperD. FentonB.H.J.G. pH stability and activity curves of pepsin with special reference to their clinical importance.Gut196565506508
    [Google Scholar]
  7. NieL. Optimum experimental designs. AC Atkinson, AN Donev and RD Tobias, with SAS Oxford.University Press, OxfordWiley Online Library.2007
    [Google Scholar]
  8. PantwalawalkarJ. NangareS. Formulation of silk fibroin-based single polymeric floating microspheres for sustained release of lafutidine.Indian Journal of Pharmaceutical Education and Research202256239640410.5530/ijper.56.2.59
    [Google Scholar]
  9. GhodakeJ. Formulation and evaluation of floating microsphere containing anti-diabetic (metformin hydrochloride) drug.Int. J. Pharm. Tech. Res.201021378384
    [Google Scholar]
  10. SoppimathK.S. KulkarniA.R. AminabhaviT.M. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: Preparation and release characteristics.Drug Dev. Ind. Pharm.200127650751510.1081/DDC‑10010517511548857
    [Google Scholar]
  11. KaleR. Preparation and evaluation of floatable drug delivery system of ketorolac tromethamine.Int. J. Pharm. Excp20013216465
    [Google Scholar]
  12. GadadA.P. Formulation and evaluation of gastroretentive floating microspheres of lafutidine.2016507681
    [Google Scholar]
  13. KawashimaY. Hollow microspheres for use as a floating controlled drug delivery system in the stomach.199281213514010.1002/jps.2600810207
    [Google Scholar]
  14. MahatoR.I. Emerging trends in oral delivery of peptide and protein drugs.2003202.310.1615/CritRevTherDrugCarrierSyst.v20.i23.30
    [Google Scholar]
  15. KawashimaY. NiwaT. TakeuchiH. HinoT. ItoY. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo).J. Control. Release199116327928910.1016/0168‑3659(91)90004‑W
    [Google Scholar]
  16. RaoM.R.P. BorateS.G. ThankiK.C. RanpiseA.A. ParikhG.N. Development and in vitro evaluation of floating rosiglitazone maleate microspheres.Drug Dev. Ind. Pharm.200935783484210.1080/0363904080262742119337874
    [Google Scholar]
  17. RahangdaleT. In vitro evaluation of floating microspheres of gabapentin by solvent evaporation method.202214210.52711/0975‑4377.2022.00023
    [Google Scholar]
  18. BhiseM. ShuklaK. JainS. BhajipaleN. SudkeS. BurakleP. Development and evaluation of floating microspheres of anticonvulsant drug by 3<sup>2</sup> full factorial design.Turkish Journal of Pharmaceutical Sciences202219559560210.4274/tjps.galenos.2021.5305036317946
    [Google Scholar]
  19. BadaouiF.Z. Statistically optimized repaglinide-loaded floating microspheres for the gastric sustained delivery via central composite design.Technology202212314061412
    [Google Scholar]
  20. Al AshmawyA.Z. Enhancement of hypolipidemic effect of atorvastatin calcium via floating microspheres.Zagazig J. Pharm. Sci.202200010.21608/zjps.2022.124307.1026
    [Google Scholar]
  21. PrajapatiB.G. PatelD.V. Formulation and optimization of domperidone fast dissolving tablet by wet granulation techniques using factorial design.International Journal of PharmTech Research20102292299
    [Google Scholar]
  22. BhardwajP. Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.The Scientific World Journal20142014
    [Google Scholar]
  23. BhopteD.K. SagarR. KoriM.L. Fabrication, optimization and characterization of floating microspheres of quinapril hydrochloride using factorial design method.Biomed. Pharmacol. J.20221542011202410.13005/bpj/2539
    [Google Scholar]
  24. ChandrikaP.N. Formulation and invitro evaluation of captopril floating microspheres.World J. Pharma. Sci.20222632
    [Google Scholar]
  25. KumarM. RaniR. VermaR. GuptaP. KumariB. PahwaR. MittalV. BhattS. KaushikD. Berberine hydrochloride embedded chitosan-based novel floating microspheres: optimization, characterization, and in vivo anti-ulcer potential.Drug Deliv. Lett.202212428730110.2174/2210303112666220602123548
    [Google Scholar]
  26. SahuR. JainS. Development and characterization of floating microspheres of dexrabeprazole sodium for the treatment of peptic ulcer.J. Drug Deliv. Ther.2022125-S202610.22270/jddt.v12i5‑S.5616
    [Google Scholar]
  27. Baghel ChauhanS. NainwaniS. Formulation and evaluation of floating microspheres for an antihypertensive drug telmisartan.Res. J. Pharm. Dos. Forms Technol.202214428328810.52711/0975‑4377.2022.00046
    [Google Scholar]
  28. KarosiyaS.R. VaidyaV.M. BhajipaleN.S. RadkeR.S. Formulation and evaluation of gastroretentive floating microspheres loaded with lamivudine.J. Drug Deliv. Ther.2022124-S172210.22270/jddt.v12i4‑S.5462
    [Google Scholar]
  29. ShahR. BhattacharyaS. Preparation and physical characterization of Methotrexate encapsulated poly (n-methyl glycine) microspheres for the Rheumatoid arthritis treatment option.Results in Chemistry2023100875
    [Google Scholar]
  30. KumarK. RaiA. Development and evaluation of floating microspheres of curcumin.Trop. J. Pharm. Res.2012115713719
    [Google Scholar]
  31. KumarS. TiwariA. GoyalN. Floating microspheres of lafutidine: Formulation, optimization, characterization, in-vitro and in-vivo floatability studies using eudragit grades.Indian J.Pharma. Edu. Res.202256368168810.5530/ijper.56.3.116
    [Google Scholar]
  32. VinchurkarK. SainyJ. KhanM.A. Development and optimization of floating alginate microspheres of repaglinide using Box-Behnken experimental design.International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)202316162816291[IJPSN].10.37285/ijpsn.2023.16.1.3
    [Google Scholar]
  33. XiongY.S. LiM-X. JiaR. ZhouL-S. FanB-H. TangJ-Y. GaiL. LiW. LuH-Q. LiK. Polyethyleneimine/polydopamine-functionalized self-floating microspheres for caramel adsorption: Interactions and phenomenological mass transfer kinetics.Separ. Purif. Tech.202331312331510.1016/j.seppur.2023.123315
    [Google Scholar]
  34. MaN. XuL. WangQ. ZhangX. ZhangW. LiY. JinL. LiS. Development and evaluation of new sustained-release floating microspheres.Int. J. Pharm.20083581-2829010.1016/j.ijpharm.2008.02.02418407442
    [Google Scholar]
/content/journals/cdth/10.2174/0115748855274979231228103038
Loading
/content/journals/cdth/10.2174/0115748855274979231228103038
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): chronic gastritis; digestive aid; enzyme; floating microspheres; Pepsin; residence time
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test